| Application no. and date | 15746399.3 (espacenet) (Federated) (European Patent Register), 20150204 | | Patent/reg. no. and date | DK/EP 3102609, 20240828 | | Publication date | 20161214 | | Priority no. and date | US 201461935833 P, 20140204 | | EP pub. no. and date |
EP 3102609 20161214 | | Effective date | | | Applicant/owner | Kite Pharma, Inc., 2225 Colorado Ave.
Santa Monica, CA 90404, US,
The United States of America, as Represented by
The Secretary, Department of Health and Human
Services, Office of Technology Transfer
National Institutes of Health
6701 Rockledge Drive
Suite 700, MSC 7788
Bethesda, Maryland 20892-7788, US | | Applicant ref. no. | V480745DK00 | | Inventor | Better, Marc, 2225 Colorado Avenue
Santa Monica, California 90404, US,
FELDMAN, Steven A., National Cancer Institute
10, Center Dr.
Bethesda, Maryland 20892-1201, US,
ROSENBERG, Steven A., National Cancer Institute
10, Center Dr.
Bethesda, Maryland 20892-1201, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , C07K 14/725 (2006.01) , C12N 5/0783 (2010.01) | | Title | Fremgangsmåder til fremstilling af autologe T-celler, der kan anvendes til at behandle B-celle-maligniteter og andre cancerformer, og sammensætninger deraf | | Int. application no. | US2015014520 | | Int. publication no. | WO2015120096 | | Related patent (certificate) | CA 2025 00009 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
